| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000033093 |
| Receipt No. | R000037694 |
| Scientific Title | The effect of comprehensive respiratory rehabilitation using cloud system on exacerbation of patients with chronic obstructive pulmonary disease at home |
| Date of disclosure of the study information | 2018/07/01 |
| Last modified on | 2021/06/12 (Ver. 2) |
| Basic information | ||
| Public title | The effect of comprehensive respiratory rehabilitation using cloud system on exacerbation of patients with chronic obstructive pulmonary disease at home | |
| Acronym | The effect of cloud system on exacerbation of patients with chronic obstructive pulmonary disease | |
| Scientific Title | The effect of comprehensive respiratory rehabilitation using cloud system on exacerbation of patients with chronic obstructive pulmonary disease at home | |
| Scientific Title:Acronym | The effect of cloud system on exacerbation of patients with chronic obstructive pulmonary disease | |
| Region |
|
|
| Condition | |||
| Condition | Chronic obstructive pulmonary disease | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | This study aims to clarify whether to prevent exacerbation by comprehensive respiratory rehabilitation at home using cloud system |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Number of exacerbations of chronic obstructive pulmonary disease 24 months after randomization |
| Key secondary outcomes | Daily physical activity |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | For the intervention group,comprehensive respiratory rehabilitation is performed using a multi-occupational cooperation tool by Vital Link (Teijin Pharma, Tokyo),and the control group is treated as usual.
The program is about 1.exercise therapy, 2. Physical activity instruction in daily life, 3. Patient education, and when intervening at the time of visit, the nurse and the caregiver confirm and intervene the contents of 1 - 3. After the intervention, the nurse and the caregiver states Program implementation status, content change and continuation. |
|
| Interventions/Control_2 | Performing a usual care in the control group | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 50 subjects who are in a stable period not suffering from exacerbations and infectious diseases such as pneumonia in patients with chronic obstructive pulmonary disease (COPD) who are seeking a Shinshu University Medical School affiliated hospital or a research cooperation facility (to be recruited) . Those that meet the eligibility criteria of 1 to 4 below are targeted. 1. Patients aged 65 years or older diagnosed with COPD (Guidelines for Diagnosis and Treatment of COPD 4th Edition, Japan Respiratory Society) 2. Shinshu University Medical School Hospital for the purpose of diagnosis and treatment of COPD Patients who visited research collaborative facilities (to be recruited) 3. Patients who obtained informed consent for this study 4. Patients who are involved in visiting rehabilitation, nursing caregivers, or caregivers | |||
| Key exclusion criteria | 1. Patients suffering from exacerbation and respiratory infection within 3 months
2. Patients who are impaired in walking or writing on question paper due to the influence of exercise function or cognitive function or difficult patients 3. Patients with complications such as severe heart failure |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shinshu university hospital | ||||||
| Division name | Rehabilitation department | ||||||
| Zip code | |||||||
| Address | 3-1-1 Asahi, Matsumoto Nagano Japan 390-8621 | ||||||
| TEL | 0263-37-2836 | ||||||
| drodman@shinshu-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Shinshu university hospital | ||||||
| Division name | Rehabilitation department | ||||||
| Zip code | |||||||
| Address | 3-1-1 Asahi, Matsumoto Nagano Japan 390-8621 | ||||||
| TEL | 0263-37-2836 | ||||||
| Homepage URL | |||||||
| drodman@shinshu-u.ac.jp | |||||||
| Sponsor | |
| Institute | Shinshu University School of Health Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000037694 |